Smart insulin pump may protect kidneys in diabetes patients

NCT ID NCT06925217

First seen Feb 18, 2026 · Last updated Apr 30, 2026 · Updated 13 times

Summary

This study tests whether a fully automated insulin delivery system (closed-loop) can improve kidney oxygen levels in adults with type 2 diabetes and moderate chronic kidney disease. About 76 participants will use either the automated system or standard insulin therapy for 26 weeks. The main goal is to see if the automated system helps kidney health, measured by special MRI scans.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHUV

    RECRUITING

    Lausanne, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Centre Hospitalier Universitaire Vaudois

    NOT_YET_RECRUITING

    Lausanne, Canton of Vaud, 1011, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.